These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 22313545
1. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway. Jiao J, Hong S, Zhang J, Ma L, Sun Y, Zhang D, Shen B, Zhu C. Cancer Lett; 2012 Jul 01; 320(1):96-103. PubMed ID: 22313545 [Abstract] [Full Text] [Related]
2. Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells. Li YX, Lin ZB, Tan HR. Acta Pharmacol Sin; 2004 Jan 01; 25(1):76-82. PubMed ID: 14704126 [Abstract] [Full Text] [Related]
3. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M. J Hepatol; 2007 Jan 01; 46(1):77-88. PubMed ID: 17045692 [Abstract] [Full Text] [Related]
7. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w. Yang X, Yin J, Yu J, Xiang Q, Liu Y, Tang S, Liao D, Zhu B, Zu X, Tang H, Lei X. Oncol Rep; 2012 Jan 01; 27(1):250-7. PubMed ID: 21947305 [Abstract] [Full Text] [Related]
8. Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition in Hep3B cells. Wang Q, Huang S, Yang L, Zhao L, Yin Y, Liu Z, Chen Z, Zhang H. Acta Biochim Biophys Sin (Shanghai); 2008 Sep 01; 40(9):819-29. PubMed ID: 18776995 [Abstract] [Full Text] [Related]
10. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Yang L, Wu D, Luo K, Wu S, Wu P. Cancer Lett; 2009 Apr 18; 276(2):180-8. PubMed ID: 19097688 [Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma and chemotherapy: the role of p53. Brito AF, Abrantes AM, Pinto-Costa C, Gomes AR, Mamede AC, Casalta-Lopes J, Gonçalves AC, Sarmento-Ribeiro AB, Tralhão JG, Botelho MF. Chemotherapy; 2012 Apr 18; 58(5):381-6. PubMed ID: 23257706 [Abstract] [Full Text] [Related]
12. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. Lu F, Hou YQ, Song Y, Yuan ZJ. Anat Rec (Hoboken); 2013 Jan 18; 296(1):56-63. PubMed ID: 23125179 [Abstract] [Full Text] [Related]